Mittal D, Young A, Stannard K, Yong M, Teng MW, Allard B, Stagg J, Smyth MJ. Antimetastatic Effects of Blocking PD-1 and the Adenosine A2A Receptor. Cancer Res. 2014 Jul 1. [Epub ahead of print]
Schuessler A, Smith C, Beagley L, Boyle GM, Rehan S, Matthews K, Jones L, Crough T, Dasari V, Klein K, Smalley A, Alexander H, Walker DG, Khanna R. Autologous T-cell therapy for cytomegalovirus as a consolidative treatment for recurrent glioblastoma. Cancer Res. 2014 Jul 1;74(13):3466-76.
Liu YC, Chen Z, Neller MA, Miles JJ, Purcell AW, McCluskey J, Burrows SR, Rossjohn J, Gras S. A Molecular Basis for the Interplay between T Cells, Viral Mutants, and Human Leukocyte Antigen Micropolymorphism. J Biol Chem. 2014 Jun 13;289(24):16688-16698.
West AC, Smyth MJ, Johnstone RW. The anticancer effects of HDAC inhibitors require the immune system. Oncoimmunology. 2014 Jan 1;3(1):e27414.
From the CIVD DirectorVaccine research requires a multi-disciplinary strategy which involves expertise in basic and applied immunology, pathogenesis, molecular and structural biology with preclinical and clinical trials methodology.
QIMR Berghofer Medical Research Institute encompasses this varied expertise within a single institution and the CIVD harnesses this to advance the science of vaccine development.
Professor Rajiv Khanna
T +61 7 3362 0385